DXCM vs HSTM: fair value comparison
DexCom, Inc. and HealthStream, Inc. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, DXCM currently sits closer to the top of our discount ranking. DXCM carries the stronger quality grade. DXCM carries the stronger momentum grade.
| DXCM | HSTM | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $90.82 | $28.33 |
| 12-month range | $58.22–$87.31 | $20.37–$28.33 |
| Sector rank | #21 of 113 Healthcare | #25 of 113 Healthcare |
| Quality grade | A | D |
| Momentum grade | A | B |
| Leverage | Moderate | Low |
| Margin trend | Contracting | — |
| Revenue growth | Strong | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Uptrend |
| DCF cross-check | Overvalued | — |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: DXCM fair value analysis · HSTM fair value analysis